•
RV
RVPHW
RVPHW
yahoo--
Price Chart
No chart data available
Market Cap
--
Volume
303.38K
52W High
$0.22
52W Low
$0.00
Open
--
Prev Close
$0.00
Day Range
-- - --
Latest News
Reviva to Present Negative Symptom Data for Brilaroxazine in Schizophrenia from the Phase 3 RECOVER Double-Blind and Open-Label Extension Trials at the CNS Summit 2025
GlobeNewswire Inc.•Oct 28
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $9 Million Public Offering
GlobeNewswire Inc.•Sep 19
Schizophrenia Market to Witness Significant Growth by 2034 Across 7MM as New Therapies Enter Late-Stage Trials | DelveInsight
GlobeNewswire Inc.•May 1
Reviva to Participate in the 2025 BIO CEO & Investor Conference
GlobeNewswire Inc.•Jan 30
5-HT2 Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
GlobeNewswire Inc.•Jan 22
Reviva Announces Proposed Public Offering
GlobeNewswire Inc.•Dec 16
Schizophrenia Clinical Trial Pipeline Insights Featuring 55+ Companies | DelveInsight
GlobeNewswire Inc.•Oct 9
Reviva Pharmaceuticals Announces Pricing of $5.0 Million Underwritten Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire Inc.•Aug 21